Home » Topics » BioWorld Science

BioWorld Science
RSS

Long-term data presented from FORWARD-2 study of ALKS-5461

May 27, 2019

BLU-5937: P2X3 homotrimeric receptor antagonist with improved taste safety profile for cough

May 27, 2019

Cyxone to seek clearance for phase I study of MS drug candidate T20K

May 24, 2019

NIAID begins phase I/II study of RSV vaccines in children aged 6-24 months

May 24, 2019

SBIR grant supports Sentia's development of astressins for IBS

May 24, 2019

Synlogic enters collaboration with Roche to study SYNB-1891 with Tecentriq in advanced tumors

May 24, 2019

Bioimics identifies bacterial ribonuclease P inhibitors

May 24, 2019

FDA grants marketing authorization to Zika virus diagnostic test

May 24, 2019

U.S. researchers present ALDH1A1 inhibitors

May 24, 2019

GlaxoSmithKline identifies IDO1 inhibitors

May 24, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...